Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

76–100 of 5,173 articles for Labels

Then save them, add them to a collection or cite them together.
  1. Research article · 10 Nov 2023

    Management of Iron Deficiency Anemia with Fixed Dose Combination of Ferrous Gluconate, Multivitamins and Multi-mineral Capsule: A 12 Week, Open Label Single Arm Prospective, Non-Interventional (Observational) Study in Philippines

    Journal of Clinical & Experimental Pharmacology · Volume 13, Issue 5

    moderate Iron Deficiency Anemia (IDA). Methods: This was a Phase IV/post-marketing, open label, single arm, prospective, non-interventional study to evaluate the SB+ capsule’s performance in real

  2. Short communication · 27 Oct 2023

    Efficacy of Micronutrient Supplementation During Antenatal Period: An Open Label Randomized Control Trial

    Indian Journal of Pharmaceutical Sciences · Volume 85, Issue 5

    open label randomized control trial was conducted to evaluate the efficacy of micronutrients among pregnant women and assessing the antenatal and fetal complications associated with the same. The participants were

  3. Article · 13 Oct 2023

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Crossover, Single Dose, Bioequivalence Study of Olmesartan medoxomil/Hydrochlorothiazide 20 mg/12.5 mg Coated Tablets of Abbott and Olmetec plusandreg;andnbsp;(Olmesartan medoxomil/Hydrochlorothiazide) 20 mg/12.5 mg Coated Tablets of Daiichi-Sankyo in Healthy, Adult, Human Subjects Under Fasting Condition

    Journal of Bioequivalence & Bioavailability · Volume 15, Issue 5

    coated tablets of Daiichi-Sankyo in healthy, adult, human subjects. An open label, balanced, randomized two treatments, two sequences, two periods, crossover, single dose study with washout period

  4. Research article · 5 Oct 2023

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Crossover, Single Dose, Bioequivalence Study of Olmesartan Medoxomil/Hydrochlorothiazide 40 mg/12.5 mg Coated Tablets of Abbott and Olmetec Plus® (Olmesartan Medoxomil/Hydrochlorothiazide) 40 mg/12.5 mg Coated Tablets of Daiichi-Sankyo in Healthy, Adult, Human Subjects Under Fasting Condition

    Journal of Bioequivalence & Bioavailability · Volume 15, Issue 4

    Coated Tablets of Daiichi- Sankyo in healthy, adult, human subjects. An open label, balanced, randomized two treatments, two sequences, two periods, crossover, single dose study with washout period

  5. Research article · 5 Oct 2023

    An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Crossover, Single Dose, Oral Bioequivalence Study of Femelle 20 (Drospirenone 3 Mg and Ethinyl Estradiol 0.02 Mg) Coated Tablets of Abbott and Yaz® (Drospirenone 3 Mg And Ethinyl Estradiol 0.02 Mg) Coated Tablets of Bayer in Healthy, Adult, Human Female Subjects Under Fasting Condition

    Journal of Bioequivalence & Bioavailability · Volume 15, Issue 4

    tablets of Bayer under fasting condition in healthy non-pregnant female subjects. An open label, balanced, randomized, two treatments, two sequences, two periods, crossover, single dose study with washout period

  6. Review article · 5 Jul 2023

    The Influence of Health Consciousness, Nutritional Labelling, and Subjective Norms on Consumer Purchase Intentions of Healthy Packaged Foods

    Academy of Marketing Studies Journal · Volume 27, Issue 5

    food products in India. The indirect impact is measured using health consciousness and nutritional label as constructs which are mediating the relationship. Healthy packaged food offers convenient and accessible options…

  7. Research article · 28 Jun 2023

    An Open Label, Balanced, Randomized, Two Treatments, Three Sequences, Three Periods, Single Dose, Semi-Replicate, Crossover, Oral Bioequivalence Study of Palbociclib 125 Mg Capsules of Abbott Laboratories De Colombia Versus Ibrance (Palbociclib) 125 Mg Capsules of Pfizer in Healthy, Adult, Human Subjects Under Fed Conditions

    Journal of Bioequivalence & Bioavailability · Volume 15, Issue 3

    Colombia vs. Ibrance (Palbociclib) 125 mg Capsules of Pfizer in healthy subjects. An open label, balanced, randomized, two treatments, three sequences, three periods, single dose, semi replicate, cross over with

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels